Webinar
Deep Tech Fund Last Call
Join Matt Caspari, Managing Partner of Alumni Ventures’ Deep Tech Fund, for a final overview of the fund’s strategy, portfolio construction, and investment thesis — and what accredited investors should understand before the fund closes to new commitments.
Matt will explain how the Deep Tech Fund identifies and evaluates companies using breakthrough science and engineering to address complex, high-impact challenges across areas such as artificial intelligence, biotechnology, energy, space, and advanced manufacturing. He’ll also cover how the fund is structured, how the team builds a diversified portfolio, and where it sees compelling opportunities emerging across the deep tech landscape.
Whether you’ve been following the fund, are evaluating venture capital for the first time, or want exposure to technologies with the potential to reshape major industries, this session will provide a clear view of the strategy and how to participate. Register for this final opportunity to hear directly from Matt and determine whether the Deep Tech Fund aligns with your investment goals before it closes.
Want to access our Deep Tech Fund startup deals to see, evaluate, and optionally invest? No cost, no commitment.
Why Attend?
- HomeUnderstand the investment thesis and technology categories guiding the Deep Tech Fund
- HomeLearn how the team evaluates technically complex companies and constructs a diversified venture portfolio
- HomeExplore how to participate before the Deep Tech Fund closes to new commitments
Rated a Top 20 VC Firm by both TIME and CB Insights.
Alumni Ventures is America’s largest venture capital firm for individual investors.
About your presenter
Overview
Matt Caspari invests in mission-driven founders building the next generation of iconic companies—entrepreneurs tackling the world’s hardest, highest-stakes problems. He backs breakthrough technologies with the potential to redefine critical industries, unlock new markets, and create a more sustainable, secure future.
Before Alumni Ventures, Matt was a two-time venture-backed founder/CEO and a leader of the innovation team at Nike. He founded Aurora Biofuels, a deep-tech venture that grew to 100+ employees and secured more than $100 million in funding before its acquisition by Reliance Industries. Earlier, he advised life science multinationals at Cambridge Pharma Consultancy (acquired by IMS Health) and gained experience on Bloomberg’s M&A team. Matt holds a BS in Biochemistry from Georgetown University and an MBA with a Certificate in Entrepreneurship from UC Berkeley.
Funds actively worked on
Investment Area of Focus
His investment lens favors bold solutions to global challenges and durable advantages rooted in technology and aligned with long-term megatrends. This translates to surgical robots powered by physical AI, next-generation energy systems, space-based infrastructure, longevity therapeutics, and more. The through-line is the potential for extraordinary value creation at the intersection of deep science and global need.
Representative investments Matt has led for Alumni Ventures include Andromeda Surgical and Cytronic (Physical AI); Arda Therapeutics and Cambrian Biopharma (Technologies for the Human Body); Max Space and Orbital Operations (Space Infrastructure); and Fortera and Mainspring Energy (The New Energy Stack). Alumni Ventures’ Deep Tech portfolio also includes companies such as Axiom Space, Ayar Labs, Cohere, Frore Systems, Groq, Hawkeye360, Hayden AI, Lambda, Radiant, and Rigetti (Nasdaq: RGTI).